Influenza Immunization: Clinical Trials

2 completed. 2 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	2	Completed 2

Follow Influenza Immunization: new trials by email Literature Review of Influenza Immunization trials Research Report on Influenza Immunization

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Fluzone Quadrivalent vaccine, No Preservative (0.5-mL dose), 2021-2022 formulation, Fluzone High-Dose Quadrivalent vaccine (0.7-mL dose), 2021-2022 formulation - Influenza Immunization, Healthy Volunteers	Phase 4	Completed	Sanofi Pasteur, a Sanofi Company	90	2021-09-08	2025-09-12
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Fluzone Quadrivalent vaccine, No Preservative (0.5-mL dose), 2020-2021 formulation, Fluzone High-Dose Quadrivalent vaccine (0.7-mL dose), 2020-2021 formulation - Influenza Immunization, Healthy Volunteers	Phase 4	Completed	Sanofi Pasteur, a Sanofi Company	90	2020-09-16	2025-09-12

Narrower conditions

Influenza, Human (2)

Broader conditions

Infections (2)  ·  Orthomyxoviridae Infections (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)

Interventions

Influenza Vaccines (2)  ·  Vaccines, Combined (2)

Sponsors

Sanofi Pasteur, a Sanofi Company (2)

Countries

United States (2)